Cure Alzheimer’s Fund award aimed at better understanding microglia’s role
Contact: Steven Lee, (210) 450-3823, lees22@uthscsa.edu
SAN ANTONIO, Feb. 20, 2026 – A researcher with the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases at UT Health San Antonio has received a two-year, $402,500 grant award from the Cure Alzheimer’s Fund to study how microglia, the brain’s resident immune cells, paradoxically might contribute to the spread of toxic forms of tau protein in the disease.
Sarah C. Hopp, PhD, associate professor of pharmacology with the Biggs Institute and the South Texas Alzheimer’s Disease Research Center, along with her lab have been instrumental in uncovering the behavior of microglia. UT Health San Antonio is the academic health center of The University of Texas at San Antonio.
Starting this month, Hopp’s lab will test the hypothesis that microglial uptake of tau is a key mechanism driving its spread through the brain, and that specific molecular pathways determine whether this process protects or harms neurons. The Cure Alzheimer’s Fund, also known as CureAlz, is a nonprofit organization that funds research “with the highest probability of preventing, slowing or reversing Alzheimer’s disease.”
A paper describing Hopp’s upcoming study published on the CureAlz website, titled, “How Do Microglia Contribute to the Spread of Tau Pathology in Alzheimer’s Disease?”, says that while tau aggregates are a defining feature of Alzheimer’s disease and closely track with brain cell loss, memory problems and cognitive decline, much still isn’t known about how it spreads or what role the brain’s immune system plays in the process.
There is evidence, it says, that toxic forms of tau, which have become “misfolded” or dysfunctional, act like a “bad influence.”
“When they encounter nearby healthy tau proteins, they cause them to misfold as well, triggering a chain reaction that spreads from one brain region to another,” according to the paper. “Microglia … are among the first to encounter these toxic tau ‘seeds.’ Normally, microglia protect the brain by clearing debris and helping repair damage. But growing evidence suggests that microglia may also contribute to tau’s spread by engulfing misfolded tau and inadvertently releasing it, thereby amplifying its harmful effects.”
Stressed microglia can release toxins
The paper notes that Hopp’s team already has identified the cellular machinery that allows microglia to internalize tau and mapped the control points that determine whether microglia successfully destroy it or release it back into the brain – finding that only about one-quarter of microglia take up misfolded tau.
The team also has discovered that this subpopulation expresses a unique set of genes linked to endocytosis (the process by which microglia engulf tau), stress in the cell’s recycling centers (lysosomes) and migration.
These changes suggest that when microglia ingest too much tau, their ability to properly digest it breaks down, leading them to release inflammatory signals and possibly spread tau instead of clearing it, the paper says.
Additional experiments confirmed this pattern: Early on, microglia reduced tau buildup, but over time, stress in their lysosomes caused them to release tau “seeds” that could spread pathology further.
The team also has discovered that the receptor LRP1 (for low-density lipoprotein receptor-related protein 1) is essential for tau uptake, because removing LRP1 sharply reduced the amount of tau internalized by microglia.
Taken together, these findings suggest that while microglia initially help protect the brain by clearing tau, prolonged stress or genetic vulnerabilities can flip that protective process into one that worsens the disease, the paper says.
The Hopp team’s new mission
Hopp’s team will pursue three complementary aims:
- Identify what makes certain microglia more likely to engulf tau than others – Using advanced gene-expression mapping, human stem-cell-derived microglia and postmortem Alzheimer’s disease brain tissue, they will define the distinct “fingerprint” of these tau-engulfing cells. This will help reveal which cellular features or environmental cues push microglia toward this specialized role.
- Study how microglia shift from being tau cleaners to tau spreaders – The team will focus on two processes: microglial migration and the lysosomal or recycling system to pinpoint when and how the protective roles of microglia break down. Understanding this transition could uncover new intervention points to preserve healthy microglial function.
- Test whether tau uptake through receptor LRP1 is essential for disease progression – Using mice engineered to have microglia that lack LRP1, they will determine whether blocking this pathway slows or prevents the spread of tau across connected brain regions.
“Together, these studies will clarify whether microglia act as barriers or accelerators in the cascade of Alzheimer’s disease,” the paper concludes. “By identifying the molecular switches that control this process, Dr. Hopp’s work could open the door to new treatments aimed at keeping microglia in their protective mode – clearing toxic proteins rather than helping them spread.
UT Health San Antonio is the academic health center of The University of Texas at San Antonio (UT San Antonio), offering a comprehensive network of inpatient and outpatient care facilities staffed by medical, dental, nursing and allied health professionals who conduct more than 2.5 million patient visits each year. It is the region’s only academic health center and one of the nation’s leading health sciences institutions, supported by the schools of medicine, nursing, dentistry, health professions, graduate biomedical sciences and public health that are leading change and advancing fields throughout South Texas and the world. To learn about the many ways “We make lives better®,” visit UTHealthSA.org.
Stay connected with UT Health San Antonio on Facebook, Twitter, LinkedIn, Instagram and YouTube.
The Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases at UT Health San Antonio is dedicated to providing comprehensive dementia care while advancing treatment through clinical trials and research. The Biggs Institute is a National Institute on Aging (NIA)-designated Alzheimer’s Disease Research Center (ADRC). UT Health San Antonio is the academic health center of The University of Texas at San Antonio (UT San Antonio). In addition to providing patient care and conducting research, the Biggs Institute partners with the School of Nursing at UT San Antonio to offer the Caring for the Caregiver program.